Published in J Neuroimmunol on March 01, 1992
Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc Natl Acad Sci U S A (2005) 1.57
Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proc Natl Acad Sci U S A (2000) 1.53
Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis. J Clin Invest (2002) 1.36
Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1). Clin Diagn Lab Immunol (2001) 0.86
Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10. Cytokine (2015) 0.85
Viability and isolation of marine bacteria by dilution culture: theory, procedures, and initial results. Appl Environ Microbiol (1993) 5.09
Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol (1999) 4.97
One or more bound planets per Milky Way star from microlensing observations. Nature (2012) 4.68
Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med (1995) 4.38
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol (1995) 4.11
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med (2000) 3.98
Discovery of a cool planet of 5.5 Earth masses through gravitational microlensing. Nature (2006) 3.53
Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis (1992) 3.37
Public-health impact of accelerated measles control in the WHO African Region 2000-03. Lancet (2005) 3.36
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02
Nurses taking on junior doctors' work: a confusion of accountability. BMJ (1996) 2.88
Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int (2007) 2.87
Instrumentation of the airway in the absence of intravenous access. Paediatr Anaesth (2003) 2.73
Calcium-dependent protein kinases play an essential role in a plant defence response. EMBO J (2001) 2.53
Can prosody aid the automatic classification of dialog acts in conversational speech? Lang Speech (2000) 2.51
Treating sexually abused children with posttraumatic stress symptoms: a randomized clinical trial. J Am Acad Child Adolesc Psychiatry (2000) 2.33
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature (1996) 2.30
The organization of the araBAD operon of Escherichia coli. Gene (1986) 2.16
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med (1999) 2.11
Evidence-based recommendations for the use of Negative Pressure Wound Therapy in traumatic wounds and reconstructive surgery: steps towards an international consensus. Injury (2011) 2.07
Cause of death and correlation with autopsy findings in burns patients. Burns (2012) 2.07
CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods (1994) 2.01
Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet (2001) 1.95
The Use of a Helium-Oxygen Mixture during Maximum Expiratory Flow to Demonstrate Obstruction in Small Airways in Smokers. J Clin Invest (1975) 1.93
Laparoscopically assisted vaginal hysterectomy superfluous? S Afr Med J (1998) 1.92
Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries. Neurology (2012) 1.92
The relationships between interphase Schwann cells and axons before myelination: a quantitative electron microscopic study. Dev Biol (1973) 1.91
Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature (1993) 1.89
Axillary plexus block using a peripheral nerve stimulator: single or multiple injections. Can J Anaesth (1992) 1.87
Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis. J Rheumatol (2001) 1.86
Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature (1995) 1.85
Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med (1997) 1.81
Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology (1999) 1.80
Bradycardia during sleep apnea. Characteristics and mechanism. J Clin Invest (1982) 1.74
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Mult Scler (2012) 1.74
CD4+CD28- costimulation-independent T cells in multiple sclerosis. J Clin Invest (2001) 1.74
[Nucleotide sequence determination of yeast mitochondrial phenylalanine-tRNA]. C R Acad Sci Hebd Seances Acad Sci D (1978) 1.73
A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis. Brain (2009) 1.69
Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study. Neurology (2009) 1.69
Rotavirus epidemiology in Vellore, south India: group, subgroup, serotype, and electrophoretype. J Clin Microbiol (1988) 1.60
Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J Immunol (1985) 1.55
[Age dependence of laboratory parameters in a health study--attempt at calculating a laboratory index for assessing biological aging]. Z Gerontol Geriatr (2002) 1.53
A systematic approach to spinal reconstruction after anterior decompression for neoplastic disease of the thoracic and lumbar spine. Neurosurgery (1993) 1.52
Retroviral marking identifies grafted autologous keratinocytes in porcine wounds receiving cultured epithelium. J Invest Dermatol (1997) 1.52
Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol (2008) 1.51
A radioimmunoassay for human antigen-antibody complexes in clinical material. J Immunol (1975) 1.51
Estrogen receptor: a prognostic factor in breast cancer. Cancer (1981) 1.51
Megadose corticosteroids in multiple sclerosis. Neurology (1994) 1.50
Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol (1992) 1.50
The use of fibrin glue in skin grafts and tissue-engineered skin replacements: a review. Plast Reconstr Surg (2001) 1.50
Carbon substrate utilization studies of some cultures of Alcaligenes denitrificans, Alcaligenes faecalis, and Alcaligenes odorans isolated from clinical specimens. J Clin Microbiol (1978) 1.48
Atracurium and vecuronium interaction with gentamicin and tobramycin. Can J Anaesth (1989) 1.47
Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition. J Exp Med (1985) 1.46
Primary pulmonary hypertension favorable effect of isoproterenol. N Engl J Med (1976) 1.46
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2011) 1.46
Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis. Ann Neurol (1998) 1.45
Complex visual disturbances in Alzheimer's disease. Neurology (1990) 1.45
Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. J Immunol (1998) 1.44
Use of overpressure to assess the role of bubbles in focused ultrasound lesion shape in vitro. Ultrasound Med Biol (2001) 1.44
Mapping and complementation studies of the gene for release factor 1. J Bacteriol (1986) 1.43
Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest (2001) 1.43
Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int Immunol (1992) 1.43
Interactions within the yeast Sm core complex: from proteins to amino acids. Mol Cell Biol (1998) 1.42
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity (2001) 1.42
[Videolaryngoscopy, for everybody?]. Ann Fr Anesth Reanim (2012) 1.40
Demonstration of epidermal transfer from a polymer membrane using genetically marked porcine keratinocytes. Burns (2001) 1.40
Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors. Nat Struct Biol (1999) 1.40
Monitoring the frequency of side effects of drugs. Reasons for stopping drugs could be recorded in general practice. BMJ (1996) 1.39
Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med (1999) 1.39
Clinical, electrical and mechanical correlations during recovery from neuromuscular blockade with vecuronium. Can J Anaesth (1990) 1.38
Characterization of some groups of gram-negative nonfermentative bacteria by the carbon source alkalinization technique. J Clin Microbiol (1981) 1.37
Protein A-peroxidase: a valluable tool for the localization of antigens. J Histochem Cytochem (1977) 1.37
In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother (1995) 1.35
Cryptic peripheral ribosomal domains distributed intermittently along mammalian myelinated axons. J Neurosci (2000) 1.35
Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. J Immunol (1983) 1.35
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials. Neurology (2004) 1.34
Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events. J Immunol (1999) 1.34
Measles immunity in a population of healthcare workers. Infect Control Hosp Epidemiol (1994) 1.33
Evidence-based recommendations for negative pressure wound therapy: treatment variables (pressure levels, wound filler and contact layer)--steps towards an international consensus. J Plast Reconstr Aesthet Surg (2011) 1.33
A guide to biological skin substitutes. Br J Plast Surg (2002) 1.32
Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol (1994) 1.32
In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis. J Antimicrob Chemother (1986) 1.32
Characterization of T cell lines and clones from SJL/J and (BALB/c x SJL/J)F1 mice specific for myelin basic protein. J Immunol (1985) 1.31
Intravenous drug users and AIDS: risk behaviors. Am J Drug Alcohol Abuse (1991) 1.31
Response of bone marrow to MC29 avian leukosis virus in vitro. Cancer Res (1969) 1.30
Exploring immunological specificity using synthetic peptide combinatorial libraries. Curr Opin Immunol (1999) 1.27
Purification to homogeneity, characterization and monoclonal antibodies of phospholipid-sensitive Ca2+-dependent protein kinase from spleen. Biochem J (1983) 1.27
Multiple sclerosis in twins. Neurology (1980) 1.26
Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells. Leukemia (2012) 1.25
Long-term methadone maintenance therapy: effects on liver function. Ann Intern Med (1972) 1.23
Context effects on misreading and suppression at UAG codons in human cells. Mol Cell Biol (1995) 1.22
Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis. Brain (2003) 1.22
Total UK multi-centre experience with a novel arterial occlusion device (Duct Occlud pfm). Heart (1996) 1.22
Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands. J Immunol (2001) 1.21
Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry (2000) 1.21
In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Antimicrob Agents Chemother (1996) 1.20
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol (1993) 1.20
Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann Neurol (2001) 1.20